Levent Bayman

688 total citations
18 papers, 320 citations indexed

About

Levent Bayman is a scholar working on Economics and Econometrics, Surgery and General Health Professions. According to data from OpenAlex, Levent Bayman has authored 18 papers receiving a total of 320 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Economics and Econometrics, 5 papers in Surgery and 5 papers in General Health Professions. Recurrent topics in Levent Bayman's work include Healthcare Policy and Management (4 papers), Cannabis and Cannabinoid Research (3 papers) and Child Abuse and Trauma (3 papers). Levent Bayman is often cited by papers focused on Healthcare Policy and Management (4 papers), Cannabis and Cannabinoid Research (3 papers) and Child Abuse and Trauma (3 papers). Levent Bayman collaborates with scholars based in United States, Türkiye and Sweden. Levent Bayman's co-authors include Mary Vaughan‐Sarrazin, Peter Cram, Ioana Popescu, Jessica Valestin, Ron Schey, Syed Hashmi, Zubair Malik, Hoangmai H. Pham, Resmîye Oral and Engin Çakar and has published in prestigious journals such as Diabetes, The American Journal of Gastroenterology and Medical Care.

In The Last Decade

Levent Bayman

18 papers receiving 313 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Levent Bayman United States 11 97 67 61 51 48 18 320
Daniela R. Junqueira Canada 9 69 0.7× 35 0.5× 41 0.7× 48 0.9× 28 0.6× 17 342
Fitzpatrick United States 10 69 0.7× 100 1.5× 34 0.6× 28 0.5× 15 0.3× 16 339
Elena Tseli Sweden 7 48 0.5× 22 0.3× 34 0.6× 19 0.4× 157 3.3× 12 339
Peter Garvin Sweden 11 28 0.3× 96 1.4× 39 0.6× 80 1.6× 9 0.2× 25 417
Majd Marrache United States 12 241 2.5× 50 0.7× 24 0.4× 37 0.7× 52 1.1× 63 387
Michael F. Evans Canada 10 49 0.5× 100 1.5× 23 0.4× 84 1.6× 11 0.2× 28 397
Sarah Sampsel United States 11 36 0.4× 30 0.4× 26 0.4× 37 0.7× 16 0.3× 16 416
Braden Te Ao New Zealand 12 49 0.5× 42 0.6× 31 0.5× 44 0.9× 16 0.3× 33 490
W Scaf-Klomp Netherlands 11 87 0.9× 69 1.0× 15 0.2× 38 0.7× 18 0.4× 12 384
Ioanna Kouri United States 6 34 0.4× 44 0.7× 23 0.4× 19 0.4× 22 0.5× 9 262

Countries citing papers authored by Levent Bayman

Since Specialization
Citations

This map shows the geographic impact of Levent Bayman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Levent Bayman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Levent Bayman more than expected).

Fields of papers citing papers by Levent Bayman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Levent Bayman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Levent Bayman. The network helps show where Levent Bayman may publish in the future.

Co-authorship network of co-authors of Levent Bayman

This figure shows the co-authorship network connecting the top 25 collaborators of Levent Bayman. A scholar is included among the top collaborators of Levent Bayman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Levent Bayman. Levent Bayman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Senior, Peter, Michael R. Rickels, Thomas L. Eggerman, et al.. (2020). 360-OR: BETA-2 Score Is Highly Correlated with Acute Insulin Response to Intravenous Glucose: An Analysis of the Clinical Islet Transplantation Consortium Trials. Diabetes. 69(Supplement_1). 2 indexed citations
2.
Bayman, Levent, et al.. (2019). Two-generational trauma-informed assessment improves documentation and service referral frequency in a child protection program. Child Abuse & Neglect. 101. 104327–104327. 9 indexed citations
3.
Zur‐Mühlen, Bengt von, Torbjörn Lundgren, Levent Bayman, et al.. (2018). Open Randomized Multicenter Study to Evaluate Safety and Efficacy of Low Molecular Weight Sulfated Dextran in Islet Transplantation. Transplantation. 103(3). 630–637. 27 indexed citations
4.
Çakar, Engin, Gülseren Akyüz, Oğuz Durmuş, et al.. (2016). The relationships of motor-evoked potentials to hand dexterity, motor function, and spasticity in chronic stroke patients: a transcranial magnetic stimulation study. Acta Neurologica Belgica. 116(4). 481–487. 32 indexed citations
5.
Malik, Zubair, et al.. (2016). Dronabinol increases pain threshold in patients with functional chest pain: a pilot double-blind placebo-controlled trial. Diseases of the Esophagus. 30(2). n/a–n/a. 39 indexed citations
6.
Reichenbach, Zachary Wilmer, et al.. (2015). A 4-week Pilot Study With the Cannabinoid Receptor Agonist Dronabinol and Its Effect on Metabolic Parameters in a Randomized Trial. Clinical Therapeutics. 37(10). 2267–2274. 9 indexed citations
7.
8.
Malik, Zubair, et al.. (2014). Dronabinol Increases Pain Threshold in Non-cardiac Chest Pain: A Double-Blind Placebo-Controlled Trial: ACG Auxiliary Award -- Trainee. The American Journal of Gastroenterology. 109. S32–S32. 1 indexed citations
9.
Bayman, Levent, et al.. (2014). Comparison of clinical features in patients with eosinophilic esophagitis living in an urban and rural environment. Diseases of the Esophagus. 28(1). 19–24. 16 indexed citations
10.
Oral, Resmîye, Kristen Jogerst, Levent Bayman, et al.. (2013). Staff training makes a difference: improvements in neonatal illicit drug testing and intervention at a tertiary hospital. The Journal of Maternal-Fetal & Neonatal Medicine. 27(10). 1049–1054. 5 indexed citations
11.
Oral, Resmîye, et al.. (2012). Perinatal illicit drug screening practices in mother-newborn dyads at a university hospital serving rural/semi-urban communities: translation of research to quality improvement. The Journal of Maternal-Fetal & Neonatal Medicine. 25(11). 2441–2446. 1 indexed citations
12.
Oral, Resmîye, et al.. (2011). Illicit Drug Exposure in Patients Evaluated for Alleged Child Abuse and Neglect. Pediatric Emergency Care. 27(6). 490–495. 27 indexed citations
13.
Vaughan‐Sarrazin, Mary, Levent Bayman, Gary J. Rosenthal, et al.. (2011). The business case for the reduction of surgical complications in VA hospitals. Surgery. 149(4). 474–483. 22 indexed citations
14.
Cram, Peter, Levent Bayman, Ioana Popescu, et al.. (2010). Uncompensated care provided by for-profit, not-for-profit, and government owned hospitals. BMC Health Services Research. 10(1). 90–90. 24 indexed citations
15.
Cram, Peter, Levent Bayman, Ioana Popescu, & Mary Vaughan‐Sarrazin. (2009). Racial Disparities in Revascularization Rates Among Patients With Similar Insurance Coverage. Journal of the National Medical Association. 101(11). 1132–1139. 50 indexed citations
16.
Cram, Peter, et al.. (2009). Acute Myocardial Infarction and Coronary Artery Bypass Grafting Outcomes in Specialty and General Hospitals: Analysis of State Inpatient Data. Health Services Research. 45(1). 62–78. 11 indexed citations
17.
Vaughan‐Sarrazin, Mary, Levent Bayman, & Peter Cram. (2009). Trends During 1993-2004 in the Availability and Use of Revascularization After Acute Myocardial Infarction in Markets Affected by Certificate of Need Regulations. Medical Care Research and Review. 67(2). 213–231. 9 indexed citations
18.
Cram, Peter, Hoangmai H. Pham, Levent Bayman, & Mary Vaughan‐Sarrazin. (2008). Insurance Status of Patients Admitted to Specialty Cardiac and Competing General Hospitals. Medical Care. 46(5). 467–475. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniela R. Junqueira Breakdown of academic impact, for papers by Fitzpatrick Breakdown of academic impact, for papers by Elena Tseli Breakdown of academic impact, for papers by Peter Garvin Breakdown of academic impact, for papers by Majd Marrache Breakdown of academic impact, for papers by Michael F. Evans Breakdown of academic impact, for papers by Sarah Sampsel Breakdown of academic impact, for papers by Braden Te Ao Breakdown of academic impact, for papers by W Scaf-Klomp Breakdown of academic impact, for papers by Ioanna Kouri
Rankless by CCL
2026